Stocks

The table gives an overview of all stocks, alphabetically sorted.
 Admicom Oyj ADMCM Apr 18, 2019 36.50 +1.39   
 Afarak Group AFAGR Apr 18, 2019 0.83 -1.19   
 Ahlstrom-Munksjö AM1 Apr 18, 2019 14.34 +3.46   
 Ahola Transport AHOLA Apr 18, 2019 0.80 0.00   
 Aktia Bank AKTIA Apr 18, 2019 9.00 0.00   
 Alma Media ALMA Apr 18, 2019 6.12 +0.33   
 Altia ALTIA Apr 18, 2019 7.84 +1.03   
 Amer Sports A AMEAS Apr 18, 2019 41.25 +3.02   
 Apetit APETIT Apr 18, 2019 8.52 -0.93   
 Asiakastieto Group ATG1V Apr 18, 2019 27.50 -0.36   
 Aspo ASPO Apr 18, 2019 8.66 -0.69   
 Aspocomp Group ACG1V Apr 18, 2019 4.50 +2.27   
 Atria A ATRAV Apr 18, 2019 9.17 +0.33   
 Basware BAS1V Apr 18, 2019 21.50 -0.69   
 BBS-Bioactive Bone Substitutes BONEH Apr 18, 2019 3.08 0.00   
 Biohit B BIOBV Apr 18, 2019 3.06 +0.66   
 Bittium BITTI Apr 18, 2019 6.72 -0.89   
 CapMan CAPMAN Apr 18, 2019 1.64 -0.24   
 Cargotec CGCBV Apr 18, 2019 37.56 +2.29   
 Caverion CAV1V Apr 18, 2019 6.11 -2.86   
 Citycon CTY1S Apr 18, 2019 9.10 +0.78   
 Componenta CTH1V Apr 18, 2019 0.13 0.00   
 Consti Yhtiöt CONSTI Apr 18, 2019 5.50 +0.37   
 Cramo CRA1V Apr 18, 2019 19.12 +0.05   
 Detection Technology DETEC Apr 18, 2019 20.80 0.00   
 Digia DIGIA Apr 18, 2019 2.92 0.00   
 Digitalist Group DIGIGR Apr 18, 2019 0.05 +0.42   
 DNA DNA Apr 18, 2019 21.10 0.00   
 Dovre Group DOV1V Apr 18, 2019 0.23 +1.75   
 Efecte PLC EFECTE Apr 18, 2019 4.71 -2.89   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK